Ann Oncol
- KELSEN D, Ben-Aharon I, Gordon N
Identifying Genetic Loci Associated with an Increased Risk for Early Onset
Colorectal Cancer.
Ann Oncol. 2024 Apr 3:S0923-7534(24)00106-6. doi: 10.1016/j.annonc.2024.
BMC Cancer
- LEE KH, Yang IJ, Ha GW, Lee J, et al
mFOLFIRINOX versus mFOLFOX 6 as adjuvant treatment for high-risk stage III colon
cancer - the FROST trial: study protocol for a multicenter, randomized
controlled, phase II trial.
BMC Cancer. 2024;24:397.
- GHOFRANI-SHAHPAR M, Pakravan K, Razmara E, Amooie F, et al
Cancer-associated fibroblasts drive colorectal cancer cell progression through
exosomal miR-20a-5p-mediated targeting of PTEN and stimulating interleukin-6
production.
BMC Cancer. 2024;24:400.
BMC Gastroenterol
- MATSUBARA D, Soga K, Ikeda J, Kumano T, et al
Impact of severe postoperative complications on the prognosis of older patients
with colorectal cancer: a two-center retrospective study.
BMC Gastroenterol. 2024;24:125.
Br J Cancer
- RIO-VILARINO A, Cenigaonandia-Campillo A, Garcia-Bautista A, Mateos-Gomez PA, et al
Correction: Inhibition of the AURKA/YAP1 axis is a promising therapeutic option
for overcoming cetuximab resistance in colorectal cancer stem cells.
Br J Cancer. 2024 Apr 4. doi: 10.1038/s41416-024-02667.
- TIAN Y, Lin Y, Qu C, Arndt V, et al
Genetic risk impacts the association of menopausal hormone therapy with
colorectal cancer risk.
Br J Cancer. 2024 Apr 1. doi: 10.1038/s41416-024-02638.
Cancer Lett
- JIANG C, Zhou Q, Yi K, Yuan Y, et al
Colorectal cancer initiation: Understanding early-stage disease for intervention.
Cancer Lett. 2024 Apr 2:216831. doi: 10.1016/j.canlet.2024.216831.
- ZHOU Y, Li H, Zhang Y, Zhao E, et al
Deubiquitinase USP4 suppresses antitumor immunity by inhibiting IRF3 activation
and tumor cell-intrinsic interferon response in colorectal cancer.
Cancer Lett. 2024 Mar 29:216836. doi: 10.1016/j.canlet.2024.216836.
Clin Cancer Res
- MOUILLET-RICHARD S, Cazelles A, Sroussi M, Gallois C, et al
Clinical challenges of consensus molecular subtype CMS4 colon cancer in the era
of precision medicine.
Clin Cancer Res. 2024 Apr 2. doi: 10.1158/1078-0432.CCR-23-3964.
Discov Oncol
- GUAN X, Cui L, Ruan Y, Fang L, et al
Heterogeneous expression of ARID1A in colorectal cancer indicates distinguish
immune landscape and efficacy of immunotherapy.
Discov Oncol. 2024;15:92.
Eur J Surg Oncol
- CAI Y, Chen M, Ye F, Liu Z, et al
The clinical relevance of adjuvant chemotherapy in locally advanced rectal cancer
patients achieving near pathological complete response following neoadjuvant
chemoradiotherapy: Insights from ypT stage.
Eur J Surg Oncol. 2024;50:108001.
- KNITTER S, Raschzok N, Hillebrandt KH, Benzing C, et al
Short-term postoperative outcomes of lymphadenectomy for cholangiocarcinoma,
hepatocellular carcinoma and colorectal liver metastases in the modern era of
liver surgery: Insights from the StuDoQ|Liver registry.
Eur J Surg Oncol. 2024;50:108010.
- QIAN C, Yang W, Li M, Feng Y, et al
Negative prognostic impact of Co-mutations in TGFbeta and TP53 pathways in
surgically resected rectal tumors following neoadjuvant chemoradiotherapy.
Eur J Surg Oncol. 2024;50:108242.
- NUIJENS BW, Lindeboom R, van den Broek JJ, Geenen RWF, et al
A prediction model for lung metastases in patients with indeterminate pulmonary
nodules in newly diagnosed colorectal cancer.
Eur J Surg Oncol. 2024;50:108305.
- MALIK HZ, Siriwardena AK
Towards standardized terminology for patients with synchronous colorectal cancer
and liver metastases.
Eur J Surg Oncol. 2024;50:108315.
Gastroenterology
- WEINBERG DS, Barkun A
Liquid Biopsy for Colorectal Cancer Screening: Not So Bloody Fast.
Gastroenterology. 2024 Mar 25:S0016-5085(24)00305.
- VAN DEN PUTTELAAR R, Nascimento de Lima P, Knudsen AB, Rutter CM, et al
Effectiveness and Cost-Effectiveness of Colorectal Cancer Screening With a Blood
Test That Meets the Centers for Medicare & Medicaid Services Coverage Decision.
Gastroenterology. 2024 Mar 18:S0016-5085(24)00174.
- LADABAUM U, Mannalithara A, Weng Y, Schoen RE, et al
Comparative Effectiveness and Cost-Effectiveness of Colorectal Cancer Screening
With Blood-Based Biomarkers (Liquid Biopsy) vs Fecal Tests or Colonoscopy.
Gastroenterology. 2024 Mar 21:S0016-5085(24)00293.
Int J Cancer
- LI YJ, Wang X, Wu YJ, Zhou XY, et al
Access to colorectal cancer screening in populations in China, 2020: A
coverage-focused synthesis analysis.
Int J Cancer. 2024 Mar 30. doi: 10.1002/ijc.34938.
- BRENNER H, Weber L, Cardoso R, Heisser T, et al
Indications of sustained delay of colorectal cancer diagnoses in Germany during
the first 2 years of the COVID-19 pandemic.
Int J Cancer. 2024 Apr 1. doi: 10.1002/ijc.34943.
- MOEN L, Liu B, Bukirwa P, Chingonzoh T, et al
Trends in the incidence of colorectal cancer in sub-Saharan Africa: A
population-based registry study.
Int J Cancer. 2024 Apr 3. doi: 10.1002/ijc.34942.
- BOUVIER AM, Jooste V, Lillini R, Marcos-Gragera R, et al
Differences in survival and recurrence of colorectal cancer by stage across
population-based European registries.
Int J Cancer. 2024 Apr 5. doi: 10.1002/ijc.34944.
Int J Colorectal Dis
- WANG K, He H, Lin Y, Zhang Y, et al
A new clinical model for predicting lymph node metastasis in T1 colorectal
cancer.
Int J Colorectal Dis. 2024;39:46.
- XIA S, Zhu Y, Luo L, Wu W, et al
Prognostic value of depression and anxiety on colorectal cancer-related
mortality: a systematic review and meta-analysis based on univariate and
multivariate data.
Int J Colorectal Dis. 2024;39:45.
- YU W, Xu B, Li P
A novel log odds of positive lymph nodes-based nomogram for predicting overall
survival in patients with colorectal signet ring cell carcinoma: a SEER
population-based study.
Int J Colorectal Dis. 2024;39:44.
J Clin Oncol
- HU H, Zhang J, Li Y, Wang X, et al
Neoadjuvant Chemotherapy With Oxaliplatin and Fluoropyrimidine Versus Upfront
Surgery for Locally Advanced Colon Cancer: The Randomized, Phase III OPTICAL
Trial.
J Clin Oncol. 2024 Apr 2:JCO2301889. doi: 10.1200/JCO.23.01889.
J Natl Cancer Inst
- FANG A, Ugai T, Gurjao C, Zhong R, et al
Alcohol and colorectal cancer risk subclassified by mutational signatures of DNA
mismatch repair deficiency.
J Natl Cancer Inst. 2024 Apr 4:djae078. doi: 10.1093.
J Pathol
- MAKINO K, Ishii T, Takeda H, Saito Y, et al
Integrated analyses of the genetic and clinicopathological features of
cholangiolocarcinoma: cholangiolocarcinoma may be characterized by
mismatch-repair deficiency.
J Pathol. 2024;263:32-46.
J Surg Oncol
- ALI D, Syed M, Gamboa AC, Hawkins AT, et al
Association of omental pedicled flap with anastomotic leak following low anterior
resection for rectal cancer.
J Surg Oncol. 2024;129:930-938.
- WEHRLE CJ, Woo K, Chang J, Gamaleldin M, et al
Impact of neoadjuvant therapy on nodal harvest in clinical stage III rectal
cancer: Establishing optimum cut-offs by disease response.
J Surg Oncol. 2024;129:945-952.
- STEVANATO FILHO PR, Bezerra TS, Marques TMDM, Nahime RH, et al
A precise approach to robotic intracorporeal rectal transection and hand-sewn
purse-string anastomosis for low anterior resection.
J Surg Oncol. 2024;129:939-944.
- BEPPU T, Yamamura K, Imai K, Hayashi H, et al
Recurrence-risk stratification using the Beppu score and selection of
perioperative chemotherapy for colorectal liver metastases.
J Surg Oncol. 2024;129:893-900.
Lancet Oncol
- MARTINELLI E, Ciardiello D
Combining chemotherapy and immunotherapy for advanced anal cancer: are we ready?
Lancet Oncol. 2024;25:416-417.
- KIM S, Ghiringhelli F, de la Fouchardiere C, Evesque L, et al
Atezolizumab plus modified docetaxel, cisplatin, and fluorouracil as first-line
treatment for advanced anal cancer (SCARCE C17-02 PRODIGE 60): a randomised,
non-comparative, phase 2 study.
Lancet Oncol. 2024;25:518-528.
Oncogene
- WU Q, Wang Z, Chen S, She X, et al
USP26 promotes colorectal cancer tumorigenesis by restraining PRKN-mediated
mitophagy.
Oncogene. 2024 Apr 2. doi: 10.1038/s41388-024-03009.
Oncol Rep
- ZHANG X, He L, Li Y, Qiu Y, et al
Compound 225# inhibits the proliferation of human colorectal cancer cells by
promoting cell cycle arrest and apoptosis induction.
Oncol Rep. 2024;51:70.
PLoS One
- OKUNO K, Ikemura K, Okamoto R, Oki K, et al
CAF-associated genes putatively representing distinct prognosis by in silico
landscape of stromal components of colon cancer.
PLoS One. 2024;19:e0299827.
- WORTHINGTON J, Sun Z, Fu R, Lew JB, et al
COVID-related disruptions to colorectal cancer screening, diagnosis, and
treatment could increase cancer Burden in Australia and Canada: A modelling
study.
PLoS One. 2024;19:e0296945.
- LIANG Y, Zhang X, Li S, Wang Z, et al
Comparison of psychological interventions for anxiety, depression, fatigue and
quality of life in colorectal cancer survivors: A systematic review and network
meta-analysis protocol.
PLoS One. 2024;19:e0298589.
- PUSPITANINGTYAS H, Hutajulu SH, Fachiroh J, Anggorowati N, et al
Diverging likelihood of colon and rectal cancer in Yogyakarta, Indonesia: A cross
sectional study.
PLoS One. 2024;19:e0301191.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016